Stock Events

Stock Events

Madrigal Pharmaceuticals (MDGL) Q3 2026 Earnings

30JulConfirmed

Q4 2025

Q1 2026

Q2 2026

Next

-5.08

-3.69

-2.29

-0.9

Details

Expected EPS

-2.773934

Actual EPS

N/A

Surprise EPS

2.77

Surprise Percent

+100%

Description

Madrigal Pharmaceuticals (MDGL) will report earnings of for Q3 2026 on July 30, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.